Bottom line
RYSDX vs RYJHX: the short answer
RYSDX (Strengthening Dollar 2x Strategy Fund) and RYJHX (Japan 2x Strategy Fund) are both mutual funds.
RYJHX is cheaper at 1.53% vs 1.94% — a difference of $41 a year per $10,000 invested.
Over five years, RYSDX returned +5.4% a year vs +0.3% for RYJHX.
RYSDX has a front-end sales load of up to 4.75%; the other does not.
Updated Nov 19, 2026
RYSDX vs RYJHX side by side
| RYSDX | RYJHX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Guggenheim | Guggenheim |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 1.94% | 1.53% |
| Annual cost per $10k | $194 | $153 |
| 10-yr cost on $10k (prospectus) | $2,724 | $1,874 |
| Max front load | 4.75% | — |
| 12b-1 fee | 0.25% | 0.25% |
| 1-yr return | −18.2% | +50.8% |
| 5-yr return (annualized) | +5.4% | +0.3% |
| 10-yr return (annualized) | +1.4% | +9.6% |
| Best quarter | — | +43.7% |
| Worst quarter | — | −35.0% |
| Net assets (fund) | $2.3M | $3.8M |
| Number of holdings | 4 | 5 |
| Portfolio turnover | % | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
2 of RYSDX's top 4 holdings also appear in RYJHX's top 5.
| Holding | RYSDX | RYJHX |
|---|---|---|
| J.p. Morgan Securities Llc | 46.73% | 35.05% |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | 46.73% | 35.05% |
Source: SEC Form N-PORT
RYSDX top 10
- J.p. Morgan Securities Llc — 46.73%
- Merrill Lynch, Pierce, Fenner & Smith Incorporated — 46.73%
- Ice Futures U.s. — 0.89%
- Goldman Sachs & Co. Llc — 0.36%
RYJHX top 10
- J.p. Morgan Securities Llc — 35.05%
- Merrill Lynch, Pierce, Fenner & Smith Incorporated — 35.05%
- Chicago Mercantile Exchange — 9.65%
- Chicago Mercantile Exchange — 4.06%
- Chicago Mercantile Exchange — -2.47%
FAQ
What is the difference between RYSDX and RYJHX?
Which is cheaper, RYSDX or RYJHX?
Should I own both RYSDX and RYJHX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.